Full-Time

Sr. Director

Patient Services Analytics

Updated on 6/24/2026

EVERSANA

EVERSANA

1,001-5,000 employees

Commercial services for pharmaceutical lifecycle management

Compensation Overview

$145k - $160k/yr

Mason, OH, USA

Remote

Category
Business & Strategy (2)
,
Required Skills
Microsoft Azure
Machine Learning
Tableau
AWS
Data Analysis
Google Cloud Platform
Requirements
  • Bachelors or Masters degree in Engineering, Business, Economics/Statistics or equivalent
  • 11+ years of experience in data and analytics with direct experience working with Patient Hub/CRM, Specialty Pharmacy, Market Access data
  • Knowledge of cloud based storage, Tableau, PowerBI and other data visualization software
  • Knowledge of copay assistance programs including coupons, PAP, bridge programs, copay accumulators/maximizers and other leading industry initiatives
  • Excellent communication skills and ability to interact with all levels of customers, end users and colleagues
  • Strong collaboration and relationship-building abilities
  • Ability to adapt to new situations, solve problems on the fly, and manage multiple priorities; team-oriented and scrappiness required
  • Familiarity with Matrix organizations and ability to operate with start-up excitement
  • Understanding of AI/Machine Learning models
  • Hands-on patient services data analytics expertise: 11+ years of prior experience working with internal and external clients and data providers to enhance and execute team priorities by leveraging data and analytics; define, create and increase the consumption of Patient Services reporting artifacts including portfolio-level power stats and help RCA operational issues with KPIs
  • Client-facing: ability to present and drive progress with insights-driven storytelling to clients especially on project coordination/management updates and leading product demos of reporting and analytics solutions
  • Outcome-driven: proven ability to translate business objectives into analytical questions and work with internal IT, Analytics & Data as well as client teams and 3rd party vendors to generate analytics solutions
  • Tableau Desktop certified associate or Power BI certification
  • AWS, GCP or Azure certifications
Responsibilities
  • Contribute to a portfolio of clients and projects, providing strategic input and expertise in driving data services strategy and execution
  • Help pursue new business and maintain the health of existing accounts; assist with regular development and review of pitches and proposals
  • Act as Data and Analytics Lead in Patient Services pitches, proposals, marketing
  • Accountable for creating scalable best practices and product offerings across Copay, Reporting, Analytic and Insights solutions for EVERSANA’s Patient Services clients on performance and value on established SLAs and KPIs
  • Lead a team of Analysts (both onsite and offshore) to generate actionable artifacts and solutions; perform data deep-dives to RCA identify and help resolve access, affordability, and adherence challenges across patient access journey
  • Support clients and business partners via operational excellence, strategic thought, effective decision making and organized project prioritization and delivery; provide clear strategic vision and plan for actionable, innovative analytic solutions
  • Be a thought partner and consultant in a matrix-environment with Patient Services leaders across Client Services, Operations, Product, Innovation, Data and IT to drive timely, accurate and comprehensive resolution and outcomes
  • Contribute to developing scalable best practices and product offerings for Patient Services Analytics Team and other cross-functional departments
  • Drive understanding of how Data and Analytics fit into broader programs and pursue a commitment to improving ROI for our clients by working with Patient Services team members to ensure that Data and Analytics accomplish goals and support partners, clients and patients
  • Develop and deliver effective and persuasive presentations demonstrating the value of our Data and Analytics offerings for client teams, business development, and internal partners
  • Define and uncover core insights and offerings from data and services that help achieve P&L goals
  • Collaborating with product owners to ensure solutions meet business needs
  • Collaborating with technical resources to identify and document technical requirements and constraints
  • Writing acceptance criteria and collaborating with QA to ensure test plans address all requirements
  • Creating user experience deliverables including wireframes and navigation flows
  • Demonstrate commitment to diversity, equity, and inclusion through continuous development and managing bias
  • All other duties as assigned
  • Travel less than 25%
  • Hours 40 per week
Desired Qualifications
  • Proficiency at SQL, Tableau, PowerBI, Snowflake knowledge
  • Proficient in Microsoft Office (Word, Excel, PowerPoint, Outlook, Visio)

EVERSANA provides integrated commercial services to pharmaceutical and biotech companies across the product lifecycle. It helps with drug pricing, market access, reimbursement, patient adherence, and product delivery through a service-based model. Its solutions are delivered via a global network of 30+ locations, including consulting, market access strategies, patient services, and field deployment. The goal is to help clients bring products to market, optimize pricing and access, improve adherence, and ensure efficient delivery to improve patient outcomes and commercial performance.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Milwaukee, Wisconsin

Founded

2018

Your Connections

People at EVERSANA who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • More than 650 life sciences clients support diversified revenue streams.
  • AI-focused EVERSANA INTOUCH can improve launch execution and marketing efficiency.
  • Partner-led launches for Candel and Xcovery expand scalable pre-commercial services.

What critics are saying

  • PBM incumbents can block Waltz Health adoption through network control.
  • Single-asset launch contracts depend on FDA approvals and launch uptake.
  • Trinity’s APACME acquisition reduces regional capability and local account control.

What makes EVERSANA unique

  • Integrated commercial platform spans pricing, access, adherence, and delivery.
  • Adds market access specialization through Jen Norton’s dedicated business unit.
  • Combines commercialization with Waltz Health’s direct-to-payer purchasing model.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Flexible Work Hours

Remote Work Options

Paid Vacation

Paid Holidays

401(k) Retirement Plan

401(k) Company Match

Wellness Program

Mental Health Support

Conference Attendance Budget

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
PharmaLive
Feb 12th, 2026
EVERSANA names new chief legal officer

EVERSANA names new chief legal officer. EVERSANA has named Monica Avram as Executive Vice President and Chief Legal Officer, a strategic addition as the company scales operations and reinvents commercialization services. As Chief Legal Officer and a member of the Executive Leadership Team, Monica leads the company's global Legal and Compliance function. Her strategic leadership integrates governance, risk, and operational execution to enable innovation, strengthen enterprise performance, and drive long-term value. With more than two decades of experience at top law firms and across global Fortune 100 companies - including UnitedHealth Group and Sanofi - Avram brings deep expertise at the intersection of healthcare, law, and emerging technologies. She has built high-performing, financially disciplined legal teams, advised executive leadership and boards on enterprise strategy, and guided organizations through complex regulatory and operational environments. "As we continue to scale, it's paramount that we have top talent who can understand the complexity of our industry and bring proven track records of success," said Mark Thierer, CEO, EVERSANA. "Throughout her career, Monica has demonstrated exceptional leadership in building best-in-class legal organizations, and we're thrilled to welcome her to EVERSANA." She brings seasoned board and advisory experience across public companies and nonprofit organizations, with deep expertise in governance, oversight, and strategic leadership. Avram holds a BA in Biology from the University of Missouri - Kansas City and a Juris Doctor from Suffolk University Law School.

Business Wire
Nov 3rd, 2025
Trinity Acquires EVERSANA's APACME Services

Trinity has announced the acquisition of EVERSANA's advisory services operation in the Asia-Pacific and Middle East (APACME) regions. This strategic move will transition EVERSANA's APACME advisory services to Trinity, enhancing its global presence in life sciences commercialization solutions.

PR Newswire
Oct 23rd, 2025
OWP Pharmaceuticals Selects EVERSANA to Support U.S. Launch of SUBVENITE(R)(lamotrigine) Oral Suspension

OWP Pharmaceuticals selects EVERSANA to support U.S. Launch of SUBVENITE(R)(lamotrigine) Oral Suspension. News provided by. CHICAGO, Oct. 23, 2025 /PRNewswire/ - OWP Pharmaceuticals, a privately held, commercial-stage neuroscience specialty pharmaceutical company, today announced that EVERSANA(R), a leading provider of commercialization services to the global life sciences industry, will provide U.S. commercialization services for the launch of SUBVENITE(R)(lamotrigine) oral suspension, the company's novel treatment for epilepsy and bipolar disorders. SUBVENITE(R), approved by the U.S. Food and Drug Administration on September 16, 2025, is the first and only FDA-approved lamotrigine oral suspension in the U.S. It is designed to help improve access to epilepsy treatments as a flexible, patient-friendly alternative to tablets. Lamotrigine is widely prescribed, but is now available in a ready-to-use liquid version. SUBVENITE(R) Oral Suspension is ideal for patients who have difficulty swallowing tablets, those who require individualized dosing, or prefer liquid medication formulations. To support a successful product launch, EVERSANA is currently activating an array of services, including field deployment, data & analytics, and co-pay services. The SUBVENITE(R) launch support is part of EVERSANA and OWP's broader commercialization partnership announced in January 2022. "Market access challenges continue to be the major hurdle for patients looking for new treatment options," said Gregory Skalicky, President, EVERSANA. "Together with OWP Pharmaceuticals, we're removing barriers and helping patients find new hope." OWP Pharmaceutical's commitment to innovation for patients expands beyond the United States. Since its founding in 2014, the company has developed a unique partnership with the ROW Foundation to support humanitarian efforts for people worldwide with epilepsy. As innovative new solutions like SUBVENITE become available, OWP is committed to ensuring it reaches patients in need, as nearly 80% of people with epilepsy live in underdeveloped countries, and about 75% of them do not have access to a treatment option. "Working with EVERSANA to support commercialization efforts in the U.S. is an important milestone for patients," said Scott Boyer, Founder and President, OWP Pharmaceuticals. "But our vision continues to be much larger, that every epilepsy patient globally one day might have access through OWP Pharma and ROW Foundation, the Pharmaceutical Social Enterprise(R). To learn more about OWP Pharmaceuticals, visit www.owppharma.com. About EVERSANA EVERSANA(R) is a leading independent provider of global services to the life sciences industry. The company's integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers. The company serves more than 650 organizations, including innovative start-ups and established pharmaceutical companies, to advance life sciences solutions for a healthier world. To learn more about EVERSANA, visit eversana.com or connect through LinkedIn and X. About OWP Pharmaceuticals OWP Pharmaceuticals is a privately held, commercial-stage neuroscience specialty pharmaceutical company, dedicated to developing and commercializing novel oral liquid formulations. Based in Lisle, IL, OWP is committed to advancing therapies in neurology and psychiatry, with a mission to bring meaningful innovations to patients. Through its partnership with the ROW Foundation, OWP also supports global initiatives to improve epilepsy care and education in underserved communities worldwide. For EVERSANA Matt Braun Vice President, Corporate Communications [email protected] SOURCE EVERSANA; OWP Pharmaceuticals

Arkansas Democrat-Gazette
Aug 27th, 2025
Eversana acquires Waltz Health

Eversana, a company that helps drugmakers sell their medicines, has acquired a smaller firm called Waltz Health that helps employers and health insurance companies purchase cheaper drugs, in a bid to build an alternative to traditional pharmacy benefits middlemen in the U.S.

PharmaLive
Aug 26th, 2025
EVERSANA Merges with Waltz Health

EVERSANA merges with Waltz Health.